Clinical Commissioning Policies
This page lists the Clinical Commissioning Policies – known locally as Lavender Statements – that have been adopted by OCCG’s Board. NHS organisations caring for Oxfordshire patients must take account of these statements when considering treatment or referral to other specialists.
280 Ectropion and Entropion
282 NHS England Specialist Commissioning Services
283 Management of Haemorrhoids
284 Adhesive Capsulitis (Frozen Shoulder)
285b TVPC73 Flash Glucose System
286 Foetal Alcohol Spectrum Disorders
287b Arthroscopic Knee Surgery for Meniscal Tears
288 Continuous Subcutaneous Insulin Infusion (Insulin Pumps) for Adults with type 1 Diabetes
289a Continuous Glucose Monitors
290 Female Sterilisation
291 Myelodysplastic Syndrome
293 Prescribing of Cannabis-based Products for Medicinal Use
294 Corticosteroid Injections for Pre-patellar and Olecranon Bursitis
295a Hearing Aids for Hearing Loss in Adults
296b Policy update primary hip and knee replacement